Viewing Study NCT00297024



Ignite Creation Date: 2024-05-05 @ 4:40 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00297024
Status: COMPLETED
Last Update Posted: 2014-01-06
First Post: 2006-02-23

Brief Title: Radiotherapy - Cerebrovascular Reactivity RT-CVR Study
Sponsor: University Health Network Toronto
Organization: University Health Network Toronto

Study Overview

Official Title: MRI Changes With Administered Oxygen and Carbon Dioxide in Patients With Brain Tumors Receiving Radiotherapy A Pilot Study
Status: COMPLETED
Status Verified Date: 2014-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Brain tumours often have low oxygen levels and that makes them more resistant to radiation therapy If patients breathe the right mixture of oxygen during treatment radiation may work better In this study patients with brain tumour will undergo a special MRI test while they breathe different mixtures of oxygen and carbon dioxide to find out whether oxygen levels improve in the tumor Patients will also be asked to repeat this MRI test during the second week of radiation therapy as well as 3 months 6 months and 1 year after RT The MRI test after RT will help us understand how the blood vessels in the normal brain are affected by radiation
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None